Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells

Figure 1

Structures of complexes used in this study. (A) Perspective drawing of [PtCl2 (L)] with atomic numbering scheme in the crystal. Selected bond length (Ã…) and angles (o), Pt(1)-Cl(1) 2.2985(8), Pt(1)-Cl(2) 2.2922(8), Pt(1)-N(1) 2.016(3), Pt(1)-N(2) 2.006(3); Cl(1)-Pt(1)-Cl(2) 89.77(3), Cl(1)-Pt(1)-N(1) 94.84(7), Cl(2)-Pt(1)-N(2) 95.30(7), N(1)-Pt(1)-N(2) 80.14(10). (B) Perspective drawing of [PdCl2 (L)] with atomic numbering scheme in the crystal. Selected bond length (Ã…) and angles (o), Pd(1)-Cl(1) 2.2940(8), Pd(1)-Cl(2) 2.2832(8), Pd(1)-N(1) 2.033(2), Pd(1)-N(2) 2.025(2); Cl(1)-Pd(1)-Cl(2) 91.04(3), Cl(1)-Pd(1)-N(1) 94.02(7), Cl(2)-Pd(1)- N(2) 94.50(6), N(1)-Pd(1)-N(2) 80.49(8).

Back to article page